Leading Fenbendazole Tablets 444mg (Orray) Manufacturer in India with Assured Quality and Purity
We are a globally trusted pharmaceutical organization recognized for manufacturing and supplying Fenbendazole Tablets 444mg (Orray) that meet the highest standards of quality, purity, safety, and consistency. As a well-established Manufacturer, Exporter, and Supplier from Vapi, Gujarat, India, we deliver premium-grade Fenbendazole formulations across PAN India, Africa, the Middle East, and LTAM markets.
Our commitment to GMP-compliant manufacturing, stringent quality control systems, and regulatory-aligned processes positions us among the Leading #1 Fenbendazole Tablets 444mg Manufacturers & Suppliers in India. Every batch is produced with precision to ensure reliable therapeutic performance and long-term stability.
Fenbendazole Tablets 444mg (Orray): High-Purity Anthelmintic Formulation
Fenbendazole Tablets 444mg (Orray) are formulated as a broad-spectrum anthelmintic (dewormer) primarily used in veterinary medicine to treat a wide range of parasitic worm infections. The formulation is known for its targeted action, dependable absorption profile, and controlled potency.
Fenbendazole functions by disrupting the cellular structure of parasites, inhibiting glucose uptake and microtubule formation, leading to parasite elimination. This mechanism ensures effective results against multiple parasites with a well-tolerated safety profile when used as prescribed.
Therapeutic Applications of Fenbendazole Tablets 444mg
Our Fenbendazole Tablets 444mg are widely prescribed in veterinary practice for treating parasitic infections in:
- Dogs and Cats
- Livestock (cattle, sheep, goats)
- Poultry
- Aquaculture and Fish
Targeted Parasites Include
- Roundworms
- Hookworms
- Whipworms
- Tapeworms
- Protozoal infections such as Giardia
In recent years, Fenbendazole has gained attention in scientific discussions regarding potential adjunct research applications, including exploratory studies related to oncology. However, such use in humans is not FDA-approved and must only be considered under strict medical consultation and supervision.
Why Taj Pharma is the Best Fenbendazole Tablets 444mg Manufacturer in India
We are recognized as a Top Known Manufacturer, Exporter, and Supplier of Fenbendazole Tablets 444mg (Orray) due to our unmatched operational excellence and customer-centric approach.
Key Strengths That Define Us
- WHO-GMP & ISO Certified Manufacturing Facility
- Advanced Production Infrastructure in Vapi, Gujarat
- Strict In-House Quality Assurance & Quality Control
- Validated Manufacturing Processes
- High Batch-to-Batch Consistency
- Competitive Pricing with Export-Grade Packaging
- Timely PAN India & Global Deliveries
Our manufacturing unit is designed to scale production efficiently while maintaining regulatory compliance and pharmacopoeial standards, making us a preferred partner for bulk buyers, institutional clients, and franchise associates.
Fenbendazole Tablets 444mg PAN India Manufacturer & Supplier
We supply Fenbendazole Tablets 444mg PAN India, including major pharmaceutical hubs such as:
- Mumbai, Maharashtra
- Delhi NCR
- Ahmedabad
- Hyderabad
- Chennai
- Bengaluru
- Kolkata
As a Fenbendazole Tablets 444mg Manufacturer from Mumbai and Vapi, Gujarat, we ensure uninterrupted supply chains, responsive logistics, and reliable after-sales support.
Fenbendazole Tablets 444mg Manufacturer, Supplier & Exporter
We are counted among the premium Fenbendazole Tablets 444mg Manufacturers & Exporters in India, serving regulated and semi-regulated markets across:
- Africa
- Middle East
- LTAM (Latin America)
- Asian Countries
Our export-grade Fenbendazole Tablets are packaged and labeled in compliance with country-specific regulatory norms, ensuring smooth registration and distribution.
Fenbendazole Tablets 444mg PCD Pharma Franchise Opportunity
We offer lucrative Fenbendazole 444mg PCD Pharma Franchise and Third-Party Manufacturing opportunities across India. Our franchise model is structured to support long-term growth with:
- Monopoly-based marketing rights
- Attractive margins
- Promotional support
- Consistent product availability
- Transparent business practices
As a Fenbendazole Tablets Manufacturer, Supplier, and PCD Pharma Franchise provider, we empower partners with high-demand products and strong brand credibility.
Safety Profile and Possible Side Effects
Most side effects associated with Fenbendazole Tablets 444mg are mild and transient. They generally subside as the body adjusts to the medication.
Reported Side Effects May Include
- Nausea
- Vomiting
- Headache
- Abdominal pain
- Dizziness
- Vertigo
- Fever
- Hair loss
- Abnormal liver function tests
Medical consultation is recommended if symptoms persist or if there are concerns regarding tolerance or interactions.
Best Price Fenbendazole Tablets 444mg (Orray) in Mumbai & PAN India
We provide Fenbendazole Tablets 444mg (Orray) at the best price in Mumbai, Maharashtra, without compromising on quality. Our pricing strategy is optimized for:
- Bulk buyers
- Distributors
- Veterinary institutions
- Export partners
- PCD franchise associates
Cost efficiency, coupled with premium quality, makes us a preferred Fenbendazole Tablets 444mg Supplier in India.
Comprehensive Product Portfolio Beyond Fenbendazole
Alongside Fenbendazole Tablets 444mg, we manufacture and supply a wide range of anthelmintic and veterinary pharmaceutical formulations, including varied strengths such as Fenbendazole (Orray) 500mg, catering to diverse therapeutic needs.
Trusted Fenbendazole Tablets Manufacturer in Vapi, Gujarat
Our strategic location in Vapi, Gujarat, enables us to operate with logistical efficiency and access robust pharmaceutical ecosystems. As a Fenbendazole Tablets (Orray) Manufacturer in Vapi, Gujarat, we maintain superior control over raw materials, production timelines, and quality benchmarks.
Your Reliable Partner for Fenbendazole Tablets 444mg
We continue to lead the market as a Fenbendazole Tablets 444mg Manufacturer, Supplier, Exporter, and PCD Pharma Franchise provider, delivering excellence through innovation, compliance, and trust. Our focus remains on long-term partnerships, consistent product performance, and global healthcare advancement.
